TREO Abdominal Stent-Graft System
Bolton Medical, Inc. · Decision date Feb 18, 2026
What did the FDA approve?
FDA records P190015/S027 as a supplement to PMA P190015, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Feb 18, 2026.
FDA approval order statement
approval for design changes to the distal cap and threaded collar of the TREO Abdominal Stent-Graft delivery system
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 18, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P190015/S027
- Regulatory pathway
- PMA supplement
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- Decision code
- APPR
- Decision date
- Feb 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P190015/S025 · Related supplement
TREO Abdominal Stent-Graft System
P190015/S027 received
Application receipt date recorded by FDA.
P190015/S027 · FDA decision
Real-Time Process
P190015/S029 · Related supplement
TREO Abdominal Stent-Graft System
P190015/S026 · Related supplement
TREO Abdominal Stent-Graft System
P190015/S024 · Related supplement
TREO Abdominal Stent-Graft System
P190015/S030 · Related supplement
TREO Abdominal Stent-Graft System
Timeline entries are records held by MedtechLedger for P190015. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P190015
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TREO Abdominal Stent-Graft SystemP190015/S025 | Bolton Medical, Inc. | PMA supplement | Sep 3, 2025 | FDA |
TREO Abdominal Stent-Graft SystemP190015/S029 | Bolton Medical, Inc. | PMA supplement | Feb 19, 2026 | FDA |
TREO Abdominal Stent-Graft SystemP190015/S026 | Bolton Medical, Inc. | PMA supplement | Mar 26, 2026 | FDA |
TREO Abdominal Stent-Graft SystemP190015/S024 | Bolton Medical, Inc. | PMA supplement | Apr 13, 2026 | FDA |
TREO Abdominal Stent-Graft SystemP190015/S030 | Bolton Medical, Inc. | PMA supplement | Jun 18, 2026 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
RelayPro Thoracic Stent-Graft Delivery SystemP200045/S025 | Bolton Medical, Inc. | PMA supplement | Oct 28, 2026 | FDA |
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA supplement | Aug 4, 2026 | FDA | |
| Cook Medical Incorporated | PMA supplement | Aug 4, 2026 | FDA | |
| William Cook Europe Aps | PMA supplement | Aug 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bolton Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 799 International Pkwy., Sunrise, FL, 33325
Sources and methodology
- Original FDA record: P190015/S027
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





